Holen Sie sich die Stockscreener-App
3.2601
1.88%
0.0601
Schlusskurs vom Vortag:
$3.20
Offen:
$3.25
24-Stunden-Volumen:
18,260
Relative Volume:
0.16
Marktkapitalisierung:
$170.72M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-2.8597
EPS:
-1.14
Netto-Cashflow:
$-47.98M
1W Leistung:
-2.97%
1M Leistung:
-5.78%
6M Leistung:
+36.98%
1J Leistung:
-43.20%
1-Tages-Spanne:
$3.215
$3.38
1-Wochen-Bereich:
$3.19
$3.52
52-Wochen-Spanne:
$2.03
$6.29
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Vergleichen Sie SGHT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.26 | 167.58M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
132.34 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.68 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.41 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.97 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.26 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-08 | Hochstufung | Lake Street | Hold → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-11-04 | Herabstufung | Lake Street | Buy → Hold |
| 2024-08-21 | Eingeleitet | Lake Street | Buy |
| 2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2022-10-04 | Eingeleitet | Needham | Hold |
| 2022-07-26 | Eingeleitet | Stifel | Hold |
| 2022-02-03 | Eingeleitet | William Blair | Outperform |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Why Sight Sciences Inc. stock is trending among retail tradersAnalyst Downgrade & Verified Momentum Stock Ideas - newser.com
How Sight Sciences Inc. stock responds to policy changesGap Down & Smart Money Movement Alerts - newser.com
Is Sight Sciences Inc. stock a defensive play in 2025Layoff News & Long-Term Growth Stock Strategies - newser.com
Is a relief rally coming for Sight Sciences Inc. holdersQuarterly Market Review & Community Consensus Trade Signals - newser.com
Is it time to cut losses on Sight Sciences Inc.Quarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
Can machine learning forecast Sight Sciences Inc. recoveryJuly 2025 Spike Watch & Reliable Price Breakout Alerts - newser.com
What analysts say about Sight Sciences Inc stockStraddle and Strangle Trades & Low Entry Risk Stocks - earlytimes.in
What does recent volatility data suggest for Sight Sciences Inc.July 2025 Breakouts & Safe Capital Growth Tips - newser.com
Sector ETF performance correlation with Sight Sciences Inc.Take Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Does Sight Sciences Inc. qualify in momentum factor screeningQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Live market analysis of Sight Sciences Inc.2025 Support & Resistance & Growth Focused Investment Plans - newser.com
Intraday pattern recognizer results for Sight Sciences Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Evp Taylor Brenton sells Sight Sciences (SGHT) shares for $1,991 By Investing.com - Investing.com Canada
Sight Sciences (NASDAQ:SGHT) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Sight Sciences (NASDAQ:SGHT) Given New $4.00 Price Target at Citigroup - Defense World
Citigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $4.00 - MarketBeat
Using AI based signals to follow Sight Sciences Inc.Quarterly Portfolio Report & Target Return Focused Picks - newser.com
How Sight Sciences Inc. stock performs in interest rate cyclesWeekly Market Summary & Low Drawdown Investment Ideas - newser.com
Chart based analysis of Sight Sciences Inc. trendsQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com
Can you recover from losses in Sight Sciences Inc.2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Using data filters to optimize entry into Sight Sciences Inc.Share Buyback & Consistent Return Strategy Ideas - newser.com
What’s next for Sight Sciences Inc. stock price2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
David Badawi Sells 6,033 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Jeremy Hayden Sells 9,731 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Technical analysis overview for Sight Sciences Inc. stockWeekly Stock Analysis & AI Optimized Trading Strategy Guides - newser.com
What indicators show strength in Sight Sciences Inc.July 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Sight Sciences Inc Stock Analysis and ForecastLong-Term Investment Plans & Maximize Gains Professionally - earlytimes.in
Sight Sciences says available draw increased to $25 million under amendmentSEC filing - MarketScreener
Sight Sciences Amends Loan Agreement with Hercules - TipRanks
Sight Sciences, Inc. Amends Loan Agreement With Hercules Capital To Extend Interest-Only Period And Reallocate Tranche - MarketScreener
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):